For instance, CDKN2B‐AS1 SNPs have been associated with large tumour sizes (e.g., rs11333048 in thyroid and oral cancers) [20, 21] as well as advanced TNM stages and high metastasis risks (e.g., rs3217992 in osteosarcoma) [22]. The gene discussed is CDKN2B; the disease is neoplasm.